News
Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...
Czech researchers conducted a prospective randomized controlled trial involving 127 patients (mean age, 62.9 years; 35.1% women) with an indication for catheter ablation for atrial fibrillation ...
There are improved all-cause mortality, rhythm control, and adverse cardiac event outcomes in patients being treated with tirzepatide who have atrial fibrillation. Patients with atrial ...
The study also included patients with atrial flutter, with one in four cases missed by CART-I and two in five with Apple's device. While the results of the 483-subject study hand a win to Sky Labs ...
Atrial fibrillation (AF), gastroesophageal reflux disease (GERD) and hiatal hernias are commonly seen in clinical practice. GERD and hiatal hernias have been proposed to be a possible cause of AF ...
Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant ...
Pulsed field ablation dominated discussions and scientific sessions at Heart Rhythm 2025 in San Diego with researchers and ...
Credit: Getty Images Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation. There are improved all-cause mortality, rhythm control, ...
1 University College London Institute for Cardiovascular Science and Barts Heart Centre, St. Bartholomew's Hospital, London, UK Objectives Atrial fibrillation (AF) is associated with increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results